Published in Blood Weekly, August 15th, 2002
"Nonmyeloablative conditioning is increasingly used for transplantation in a wide range of diseases, but little is known about its impact on the incidence of infections and immune reconstitution," explained Dr. Suparno Chakrabarti and colleagues in the United Kingdom.
Stem cell recipients who underwent nonmyeloablative conditioning with Campath-1H suffered from a high CMV infection rate, although this was mitigated by their low...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.